Variant report
Variant | esv3430494 |
---|---|
Chromosome Location | chr14:104841576-104841937 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:104841247..104842926-chr14:104851671..104854407,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149349131 | chr14:104841580-104841581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549078779 | chr14:104841587-104841588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs202083980 | chr14:104841610-104841611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs565752680 | chr14:104841637-104841638 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527904354 | chr14:104841646-104841647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9671800 | chr14:104841661-104841662 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs113988128 | chr14:104841669-104841670 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561861916 | chr14:104841673-104841674 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113698888 | chr14:104841677-104841678 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141536905 | chr14:104841680-104841681 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568180614 | chr14:104841681-104841682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113277780 | chr14:104841687-104841688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181148607 | chr14:104841703-104841704 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs184625231 | chr14:104841704-104841705 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188897348 | chr14:104841708-104841709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182437231 | chr14:104841709-104841710 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535428386 | chr14:104841716-104841717 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187145672 | chr14:104841717-104841718 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9671806 | chr14:104841724-104841725 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs4076303 | chr14:104841726-104841727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112357643 | chr14:104841732-104841733 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9671796 | chr14:104841740-104841741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9671802 | chr14:104841744-104841745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577911673 | chr14:104841774-104841775 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543339441 | chr14:104841775-104841776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191201444 | chr14:104841779-104841780 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74088593 | chr14:104841788-104841789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12883506 | chr14:104841795-104841796 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs113922555 | chr14:104841803-104841804 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12883115 | chr14:104841811-104841812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12883245 | chr14:104841815-104841816 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200726125 | chr14:104841822-104841823 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs370077172 | chr14:104841823-104841824 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559501324 | chr14:104841829-104841830 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538282652 | chr14:104841833-104841834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528191031 | chr14:104841838-104841839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116586691 | chr14:104841845-104841846 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570939859 | chr14:104841850-104841851 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116122544 | chr14:104841851-104841852 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs74088594 | chr14:104841866-104841867 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs535463504 | chr14:104841871-104841872 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555298826 | chr14:104841918-104841919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Cancer | 20164920 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Congenital heart defect | 22367666 | CNVD |
Developmental delay | 22367666 | CNVD |
Genitourinary abnormalities | 22367666 | CNVD |
Intellectual disability | 22367666 | CNVD |
Microcephaly | 22367666 | CNVD |
Muscularhypotonia | 22367666 | CNVD |
Ocular coloboma | 22367666 | CNVD |
Teratozoospermia | 22367666 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 21990379 | CNVD |
Breast cancer | 16417655 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
Cancer | 21129771 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Schizophrenia | 21399695 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
14q deletion syndrome | 22511897 | CNVD |
Epilepsy | 22083797 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 17440070 | CNVD |
Neurocytoma | 17123091 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Acute lymphoblastic leukemia | 17315016 | CNVD |
Lung cancer | 17086460 | CNVD |
Mortal | 21835882 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Ependymoma | 20639864 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:104831000-104842000 | Weak transcription | Gastric | stomach |
2 | chr14:104835400-104842000 | Weak transcription | Fetal Brain Male | brain |
3 | chr14:104840200-104842000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |